Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
The present study aims at obtaining more in-depth information on how patients with chronic lymphocytic leukemia treated with idelalisib and rituximab react to treatment.
100 项与 Eric Group 相关的临床结果
0 项与 Eric Group 相关的专利(医药)
100 项与 Eric Group 相关的药物交易
100 项与 Eric Group 相关的转化医学